长效胰岛素:即将进入每周一次新时代 转载自 Armstrong 医药笔记 2023-09-06 08:52 发表于北京▎Armstrong 2000年,甘精胰岛素获批上市,迅速成为基础胰岛素的标准疗法,并在很长时间内成为最畅销的降糖药品种。此外,由于胰岛素的治疗窗口较窄,这让更长效的胰岛素进展缓慢。不过,近年来,诺和诺德、礼来的每周一次超长效胰岛素陆续获得突破,基础胰岛素很快将进入每周一次给药的新时代。
OLUMIANT is the first and only JAK inhibitor FDA-approved for the treatment of COVID-19 in certain hospitalized adults requiring various degrees of oxygen support.INDIANAPOLIS, May 11, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today the U.S. Food and
Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trialsWhile not indicated for weight loss, Mounjaro led to significantly greater weight reductions versus comparators in a key secondary endpointMounjaro represents the first new class of diabetes medicines
Diabodies are noncovalent dimers of single-chain antibody fragments that retain the avidity of intact IgG but have more favorable blood clearance than intact IgG. Radiometals offer a wide range of half-lives and emissions for matching imaging and therapy requirements and provide facile labeling of c
AbstractAn armed antibody (antibody-drug conjugate or ADC) is a vectorized chemotherapy, which results from the grafting of a cytotoxic agent onto a monoclonal antibody via a judiciously constructed spacer arm. ADCs have made considerable progress in 10 years. While in 2009 only gemtuzumab ozogamici
For semaglutide, there are different side chains and semaglutide intermediates we can provide, including Ste-Glu-AEEA-AEEA-OSU (CAS1169630-40-3), Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS 1662688-20-1) and tBuO-Ste-Glu(AEEA-AEEA-OH)OtBu ( CAS1118767-16-0) not only for the fermentation method but also for the synthesis method.